Location History:
- Raleigh, NC (US) (2003)
- Durham, NC (US) (2010)
Company Filing History:
Years Active: 2003-2010
Title: Ed Williams McLean: Innovator in Therapeutic Agents
Introduction
Ed Williams McLean is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of therapeutic agents, holding two patents that address critical health issues. His work focuses on innovative solutions for diseases related to HIV and diabetes.
Latest Patents
One of McLean's latest patents is for CCR5 antagonists as therapeutic agents. This invention relates to compounds that are useful in the treatment and prophylaxis of CCR5-related diseases and disorders. Specifically, it aims to inhibit HIV replication and prevent or treat HIV infection, as well as address the resulting acquired immune deficiency syndrome (AIDS). Another significant patent is for Kv2.1 antagonists, which involves methods for treating non-insulin dependent diabetes mellitus. This invention includes antagonists of the delayed rectifier potassium channel Kv2.1, along with methods for using and preparing these antagonists.
Career Highlights
McLean is associated with SmithKline Beecham Corporation, where he has been able to apply his innovative ideas in a corporate setting. His work has contributed to advancements in medical treatments and has the potential to improve the quality of life for many individuals suffering from chronic diseases.
Collaborations
Throughout his career, McLean has collaborated with notable colleagues, including Wieslaw Mieczyslaw Kazmierski and Christopher Joseph Aquino. These collaborations have likely enhanced the development and implementation of his innovative ideas.
Conclusion
Ed Williams McLean is a distinguished inventor whose work in therapeutic agents has the potential to make a significant impact on public health. His patents reflect a commitment to addressing critical health challenges, particularly in the areas of HIV and diabetes.